Newron Pharmaceuticals SpA is a Italy-based clinical-stage biopharmaceutical company... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MSDQX | 15.19 | 0.13 | +0.86% |
| Morgan Stanley Emerging Mkt ex China A | |||
| IDHCX | 20.50 | 0.10 | +0.49% |
| Integrity Dividend Harvest C | |||
| PFRSX | 28.50 | 0.08 | +0.28% |
| Principal Real Estate Securities Fd R6 | |||
| ATEYX | 172.79 | 0.14 | +0.08% |
| AB Sustainable Global Thematic Advisor | |||
| KCEIX | 12.10 | -0.01 | -0.08% |
| Knights of Columbus Long/Short Eq I | |||
A.I.dvisor tells us that NWPHF and MMIRF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NWPHF and MMIRF's prices will move in lockstep.
| Ticker / NAME | Correlation To NWPHF | 1D Price Change % | ||
|---|---|---|---|---|
| NWPHF | 100% | N/A | ||
| MMIRF - NWPHF | 30% Poorly correlated | -44.44% | ||
| ACET - NWPHF | 27% Poorly correlated | +0.80% | ||
| NTRB - NWPHF | 19% Poorly correlated | +1.23% | ||
| NURPF - NWPHF | 7% Poorly correlated | N/A | ||
| PRVCF - NWPHF | 4% Poorly correlated | +10.09% | ||
More | ||||